Breeze Acquisition II, a blank check company targeting global businesses in healthcare, tech, and robotics, filed on Monday with the SEC to raise up to $125 million in an initial public offering.
The company plans to raise $125 million by offering 12.5 million units at $10. Each unit consists of one share of common stock and one right to receive one-tenth of a share upon the completion of an initial business combination.
Breeze Acquisition II is led by CEO, CFO, and Chairman Douglas Ramsey, the former President and CFO of oil and well drilling company Saddle Operations, and Vice President Richard Cabell, the former Director of Finance and Administration for oil and gas exploration company Hunt Oil. The SPAC plans to target companies with enterprise values between $400 million and $1 billion, global operations, and differentiated technology or capabilities, particularly in healthcare, biotechnology, advanced manufacturing, robotics, and artificial intelligence, among others.
Management's previous SPAC, Breeze Holdings Acquisition, merged with Taiwan-based biotech YD Bio (YDES; +26% from $10 offer price) in August 2025.
The Irving, TX-based company was founded in 2025 and plans to list on the Nasdaq under the symbol BREZU. IB Capital and I-Bankers Securities are the joint bookrunners on the deal.
